The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery

被引:3
|
作者
Tasbulak, Omer [1 ]
Sahin, Anil [1 ]
机构
[1] Univ Hlth Sci, Mehmet Akif Ersoy Thorac & Cardiovasc Surg Traini, Cardiol, Istanbul, Turkey
关键词
graft; graft failure; graft patency; coronary artery bypass surgery; cha2ds2-vasc; IN-HOSPITAL MORTALITY; SAPHENOUS-VEIN; DISEASE; ATHEROSCLEROSIS; VALIDATION; BURDEN; STROKE;
D O I
10.7759/cureus.22833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective Graft patency is one of the major concerns after coronary artery bypass graft (CABG) surgery. The CHA(2)DS(2)-VASc [congestive heart failure, hypertension, age >= 75 years, diabetes mellitus (DM), stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category] score is a tool that was developed to predict the risk of thrombotic events in patients with atrial fibrillation (AF). In this study, we evaluated the use of the CHA(2)DS(2)-VASc score as a simple tool for predicting graft failure (GF) among patients who underwent CABG surgery. Methods In this retrospective case-control study, a total of 280 patients were enrolled after applying the exclusion criteria. Angiograms were analyzed by using the QCA software system (Pie Medical Imaging, Maastricht, The Netherlands) for each patient. A graft was described as failed if it had 70% or more stenosis or was completely occluded. Patients were classified into two groups: group one included patients without GF (GF-N) and group two included patients with GF (GF-Y). Thereafter, the CHA(2)DS(2)-VASc risk score was calculated for each patient. Results In our cohort, 136 patients had GF (GF-Y group) and 144 patients did not have GF (GF-N group). GF-N and GF-Y patients had their angiography performed 100.31 +/- 8.04 and 103.49 +/- 8.41 months after CABG, respectively. GF-Y group had a significantly higher rate of DM, hypertension, and heart failure with reduced ejection fraction (HFrEF). GF-Y group had higher CHA(2)DS(2) (GF-N group: 1.47 +/- 0.91 vs. GF-Y group: 2.57 +/- 1.17, p=0.0001) and CHA(2)DS(2)-VASc score (GF-N group: 2.80 +/- 1.11 vs. GE-Y group: 4.15 +/- 1.25, p=0.0001). Analyses showed that only CHA(2)DS(2)-VASc was an independent predictor of GF while other parameters including DM, hypertension, HFrEF, creatinine, and CHADS(2) were not found to be independent predictors of GE. A CHA(2)DS(2)-VASc score of >3 predicted GF with a sensitivity of 65.44% and a specificity of 74.31%. Conclusions The CHA(2)DS(2)-VASc score might be used as a feasible and simple method to predict the risk of GF after CABG surgery.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Heart failure: a weak link in CHA2DS2-VASc
    Friberg, Leif
    Lund, Lars H.
    ESC HEART FAILURE, 2018, 5 (03): : 231 - 239
  • [22] CHA2DS2-VASC Clinical Score to Predict In-Stent Restenosis
    Alfonso, Fernando
    Diez-Villanueva, Pablo
    Rivero, Fernando
    ANGIOLOGY, 2018, 69 (08) : 653 - 656
  • [23] Prognostic Value of the CHA2DS2-VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions
    Tomoi, Yusuke
    Takahara, Mitsuyoshi
    Soga, Yoshimitsu
    Fujihara, Masahiko
    Iida, Osamu
    Kawasaki, Daizo
    Kozuki, Amane
    Ando, Kenji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (11) : 1153 - 1160
  • [24] CHA2DS2-VASc and R2 CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes
    Kiliszek, Marek
    Szpakowicz, Anna
    Filipiak, Krzysztof J.
    Koltowski, Lukasz
    Poludniewska, Dominika
    Szymanski, Filip
    Peller, Michal
    Budnik, Monika
    Nargiello, Ewa
    Musial, Wlodzimierz J.
    Kaminski, Karol A.
    Opolski, Grzegorz
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (7-8): : 545 - 552
  • [25] Higher CHA2DS2-VASc Score Is Associated With Increased Mortality in Acute Pulmonary Embolism
    Onuk, Tolga
    Karatas, Mehmet Baran
    Ipek, Gokturk
    Gungor, Baris
    Akyuz, Sukru
    Canga, Yigit
    Uzun, Ahmet Okan
    Avci, Ilhan Ilker
    Osken, Altug
    Kasikcioglu, Hulya
    Cam, Nese
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) : 631 - 637
  • [26] The same old things: Ancient CHA2DS2-VASC score
    Cerit, Levent
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 61 : 324 - 324
  • [27] CHA2DS2-VASc score as a predictor of no-reflow phenomenon after saphenous vein graft percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Gurbak, Ismail
    Panc, Cafer
    Sahin, Ahmet A.
    Dervis, Emir
    Yildiz, Ibrahim
    Guler, Arda
    Demir, Ali R.
    Kahraman, Serkan
    Uzun, Fatih
    KARDIOLOGIA POLSKA, 2020, 78 (11) : 1129 - 1136
  • [28] Prognostic value of CHA2DS2 -VASc score for the long-term cardiovascular events after coronary artery bypass grafting
    Ercan, Abdulkadir
    Gurbuz, Orcun
    Culhaoglu, Zekeriya Afsin
    Kumtepe, Gencehan
    Ozkan, Hakan
    Yuksel, Ahmet
    Ener, Serdar
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 31 (04): : 479 - 488
  • [29] CHA2DS2-VASc and R2CHA2DS2-VASc scores predict mortality in high cardiovascular risk population
    D'Errico, Maria Maddalena
    Piscitelli, Pamela
    Mirijello, Antonio
    Santoliquido, Mariateresa
    Salvatori, Mauro
    Vigna, Carlo
    Vendemiale, Gianluigi
    Lamacchia, Olga
    Fontana, Andrea
    Copetti, Massimiliano
    Pontremoli, Roberto
    De Cosmo, Salvatore A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (11)
  • [30] Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation?
    Tang, Ri-Bo
    Dong, Jian-Zeng
    Liu, Xing-Peng
    Long, De-Yong
    Yu, Rong-Hui
    Du, Xin
    Liu, Xiao-Hui
    Ma, Chang-Sheng
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 1107 - 1109